The gastric fluid proteome as a potential source of gastric cancer biomarkers

Journal of Proteomics

Volumn 90, Issue , 2013, Pages 3-13

  Wu, Wei ^a   Chung, Maxey C M ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biomarker; Diagnosis; Gastric cancer; Gastric fluid; Proteomics

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A1; CA 19-9 ANTIGEN; CALCYCLIN; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARCINOEMBRYONIC ANTIGEN; CATHEPSIN B; CATHEPSIN D; CHAPERONIN 60; CYTOKERATIN 8; DESMIN; GLUCOSE REGULATED PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; KERATIN; LEUCINE ZIPPER PROTEIN; NICOTINAMIDE METHYLTRANSFERASE; NONHISTONE PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; PEPSINOGEN II; PEROXIREDOXIN 4; PROHIBITIN; PROTEOME; PYRIDOXAL KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SERUM ALBUMIN; SERUM AMYLOID P; TRANSGELIN; TUMOR MARKER; TUMOR PROTEIN;

BODY FLUID; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CHRONIC GASTRITIS; HUMAN; INTESTINE METAPLASIA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; REVIEW; STOMACH CANCER; STOMACH JUICE; STOMACH SURGERY; STOMACH ULCER; TWO DIMENSIONAL ELECTROPHORESIS; ANIMAL; METABOLISM; PATHOLOGY; STOMACH TUMOR;

ANIMALS; GASTRIC JUICE; HUMANS; NEOPLASM PROTEINS; PROTEOME; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84882586084     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.04.035     Document Type: Review

References (76)

1. Tanaka M., Ma E., Tanaka H., Ioka A., Nakahara T., Takahashi H. Trends of stomach cancer mortality in Eastern Asia in 1950-2004: comparative study of Japan, Hong Kong and Singapore using age, period and cohort analysis. Int J Cancer 2012, 130:930-936.
2. Zilberstein B., Jacob C.E., Cecconello I. Gastric cancer trends in epidemiology. Arq Gastroenterol 2012, 49:177-178.
3. Crew K.D., Neugut A.I. Epidemiology of gastric cancer. World J Gastroenterol 2006, 12:354-362.
4. Levi F., Lucchini F., Gonzalez J.R., Fernandez E., Negri E., La Vecchia C. Monitoring falls in gastric cancer mortality in Europe. Ann Oncol 2004, 15:338-345.
5. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005, 96:1-6.
6. American Cancer Society Cancer facts & figures 2012 2012, American Cancer Society, Atlanta.
7. Soybel D.I. Anatomy and physiology of the stomach. Surg Clin North Am 2005, 85:875-894.
8. Bedine M.S. Textbook of gastroenterology. Gastroenterology 2000, 118:984-985.
9. Raufman J.-P., Goldberg E. Stomach and duodenum: anatomy and structural anomalies. Textbook of gastroenterology 2009, 889-902. Blackwell Publishing Ltd.
10. Ramsay P.T., Carr A. Gastric acid and digestive physiology. Surg Clin North Am 2011, 91:977-982.
11. Zhu H., Hart C.A., Sales D., Roberts N.B. Bacterial killing in gastric juice-effect of pH and pepsin on Escherichia coli and Helicobacter pylori. J Med Microbiol 2006, 55:1265-1270.
12. Miller L.J. Gastrointestinal hormones and receptors. Textbook of gastroenterology 2009, 56-85. Blackwell Publishing Ltd.
13. Washington M.K., Peek R.M. Gastritis and gastropathy. Textbook of gastroenterology 2009, 1005-1025. Blackwell Publishing Ltd.
14. Dixon M.F., Genta R.M., Yardley J.H., Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996, 20:1161-1181.
15. Boulton R. A colour handbook. Gastroenterology 2011, 49-80.
16. Vannella L., Lahner E., Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol 2012, 18:1279-1285.
17. Dirnu R., Secureanu F.A., Neamtu C., Totolici B.D., Pop O.T., Mitrut P., et al. Chronic gastritis with intestinal metaplasia: clinico-statistical, histological and immunohistochemical study. Rom J Morphol Embryol 2012, 53:293-297.
18. Correa P., Piazuelo M.B. The gastric precancerous cascade. J Dig Dis 2012, 13:2-9.
19. Filipe M.I., Munoz N., Matko I., Kato I., Pompe-Kirn V., Jutersek A., et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994, 57:324-329.
20. Soll A.H., Graham D.Y. Peptic ulcer disease. Textbook of gastroenterology 2009, 936-981. Blackwell Publishing Ltd.
21. Lin L.L., Huang H.C., Ogihara S., Wang J.T., Wu M.C., McNeil P.L., et al. Helicobacter pylori disrupts host cell membranes, initiating a repair response and cell proliferation. Int J Mol Sci 2012, 13:10176-10192.
22. Fiocca R., Ceppa P. Endoscopic biopsies. J Clin Pathol 2003, 56:321-322.
23. Layke J.C., Lopez P.P. Gastric cancer: diagnosis and treatment options. Am Fam Physician 2004, 69:1133-1140.
24. Aurello P., D'Angelo F., Rossi S., Bellagamba R., Cicchini C., Nigri G., et al. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg 2007, 73:359-366.
25. Saiura A., Umekita N., Inoue S., Maeshiro T., Miyamoto S., Matsui Y., et al. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 2002, 49:1062-1065.
26. Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer 2002, 5:1-5.
27. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
28. Srinivas P.R., Kramer B.S., Srivastava S. Trends in biomarker research for cancer detection. Lancet Oncol 2001, 2:698-704.
29. Henson D.E., Dittus C., Younes M., Nguyen H., Albores-Saavedra J. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004, 128:765-770.
30. Cheng Y., Zhang J., Li Y., Wang Y., Gong J. Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. BMC Cancer 2007, 7:191.
31. Sousa J.K., Ham A.J., Whitwell C., Nam K.T., Lee H.J., Yang H.K., et al. Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers. Am J Pathol 2012, 181:1560-1572.
32. Good D.M., Thongboonkerd V., Novak J., Bascands J.L., Schanstra J.P., Coon J.J., et al. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res 2007, 6:4549-4555.
33. Adkins J.N., Varnum S.M., Auberry K.J., Moore R.J., Angell N.H., Smith R.D., et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 2002, 1:947-955.
34. Diamandis E.P. Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 2004, 96:353-356.
35. Hartwell L., Mankoff D., Paulovich A., Ramsey S., Swisher E. Cancer biomarkers: a systems approach. Nat Biotechnol 2006, 24:905-908.
36. Jolliffe D.M. Practical gastric physiology. Contin Educ Anaesth Crit Care Pain 2009, 9:173-177.
37. Northrop J.H. The significance of the hydrogen ion concentration for the digestion of proteins by pepsin. J Gen Physiol 1920, 3:211-227.
38. Fox H.J. Sprue; observations on the proteolytic effect of neutralized gastric juice on protein substrates, with reference to the activity of the intrinsic factor. J Clin Invest 1948, 27:534.
39. Martin L. Gastric juice: I. Studies on the proteins of the gastric juice of humans. J Biol Chem 1933, 102:113-130.
40. Glass G.B., Boyd L.J. The three main components of the human gastric mucin; dissolved mucoproteose, dissolved mucoprotein, and mucoid of the gastric visible mucus; preliminary data on physiological and clinical significance of separate quantitative determination of the dissolved mucoproteose and dissolved mucoprotein in the gastric juice of man. Gastroenterology 1949, 12:849-878.
41. Glass G.B., Pugh B.L., Wolf S. Acid-binding capacity of dialyzed mucin fractions from human gastric juice. Proc Soc Exp Biol Med 1951, 76:398-402.
42. Hiller E., Bischof H. The protein and amino acid content of human gastric juice, determined by means of electrophoresis and chromatography. Medizinische 1953, 48:1541-1545.
43. Gullberg R., Olhagen B. Electrophoresis of human gastric juice. Nature 1959, 184:1848-1849.
44. Piper D.W., Stiel M.C., Builder J.E. The electrophoretic pattern of normal human gastric juice and of the gastric juice of patients with gastric ulcer and gastric cancer. Gut 1963, 4:236-242.
45. Solovei M.G. Protein decomposition products in the gastric juice in some urological diseases. Urol Mosc 1956, 21:29-35.
46. Hakanson R., Lilja B., Owman C., Thunell S. Changes in gastric secretion induced by certain amines, amine precursors and related enzyme inhibitors. Eur J Pharmacol 1967, 1:425-433.
47. Nava G., De Bac C. Mucin fractions in the gastric juice in diagnosis of stomach diseases. Minerva Med 1951, 42:601-606.
48. Bennett A., Hogbin B.M., Physiol J. The effect of gastrin on secretion of acid by the rat stomach 1968, 198. [91passim-2p].
49. Grossman M.I. Physiological role of gastrin. Fed Proc 1968, 27:1312-1313.
50. Grossman M.I. Gastrin and its activities. Nature 1970, 228:1147-1150.
51. Duraker N., Naci Celik A., Gencler N. The prognostic significance of gastric juice CA 19-9 and CEA levels in gastric carcinoma patients. Eur J Surg Oncol 2002, 28:844-849.
52. Lee K., Kye M., Jang J.S., Lee O.J., Kim T., Lim D. Proteomic analysis revealed a strong association of a high level of alpha1-antitrypsin in gastric juice with gastric cancer. Proteomics 2004, 4:3343-3352.
53. Hsu P.I., Chen C.H., Hsieh C.S., Chang W.C., Lai K.H., Lo G.H., et al. Alpha1-antitrypsin precursor in gastric juice is a novel biomarker for gastric cancer and ulcer. Clin Cancer Res 2007, 13:876-883.
54. Hsu P.I., Chen C.H., Hsiao M., Wu D.C., Lin C.Y., Lai K.H., et al. Diagnosis of gastric malignancy using gastric juice alpha1-antitrypsin. Cancer Epidemiol Biomarkers Prev 2010, 19:405-411.
55. Paulo J.A., Lee L.S., Wu B., Repas K., Banks P.A., Conwell D.L., et al. Proteomic analysis of endoscopically (endoscopic pancreatic function test) collected gastroduodenal fluid using in-gel tryptic digestion followed by LC-MS/MS. Proteomics Clin Appl 2010, 4:715-725.
56. Liang C.R., Tan S., Tan H.T., Lin Q., Lim T.K., Liu Y., et al. Proteomic analysis of human gastric juice: a shotgun approach. Proteomics 2010, 10:3928-3931.
57. Kam S.Y., Hennessy T., Chua S.C., Gan C.S., Philp R., Hon K.K., et al. Characterization of the human gastric fluid proteome reveals distinct pH-dependent protein profiles: implications for biomarker studies. J Proteome Res 2011, 10:4535-4546.
58. Kon O.L., Yip T.T., Ho M.F., Chan W.H., Wong W.K., Tan S.Y., et al. The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile. BMC Med Genomics 2008, 1:54.
59. Wu W., Juan W.C., Liang C.R., Yeoh K.G., So J., Chung M.C. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis. Proteomics Clin Appl 2012, 6:152-162.
60. Chang W.C., Hsu P.I., Chen Y.Y., Hsiao M., Lu P.J., Chen C.H. Observation of peptide differences between cancer and control in gastric juice. Proteomics Clin Appl 2008, 2:55-62.
61. Dias A., Garcia C., Majewski M., Wallner G., McCallum R.W., Poplawski C., et al. Gastric juice prostaglandins and peptide growth factors as potential markers of chronic atrophic gastritis, intestinal metaplasia and gastric cancer: their potential clinical implications based on this pilot study. Dig Dis Sci 2011, 56:3220-3225.
62. Ruan H.L., Hong R.T., Xie H.J., Hu N.Z., Xu J.M., Zhang W. Significance of elevated levels of collagen type IV and hyaluronic acid in gastric juice and serum in gastric cancer and precancerous lesion. Dig Dis Sci 2011, 56:2001-2008.
63. Deng K., Lin S., Zhou L., Geng Q., Li Y., Xu M., et al. Three aromatic amino acids in gastric juice as potential biomarkers for gastric malignancies. Anal Chim Acta 2011, 694:100-107.
64. Teale F.W., Weber G. Ultraviolet fluorescence of the aromatic amino acids. Biochem J 1957, 65:476-482.
65. Deng K., Lin S., Zhou L., Li Y., Chen M., Wang Y. High levels of aromatic amino acids in gastric juice during the early stages of gastric cancer progression. PLoS One 2012, 7:e49434.
66. Zhou L.Y., Lin S.R., Li Y., Geng Q.M., Ding S.G., Meng L.M., et al. The intrinsic fluorescence spectrum of dilute gastric juice as a novel diagnostic tool for gastric cancer. J Dig Dis 2011, 12:279-285.
67. Hirsch R.E., Zukin R.S., Nagel R.L. Intrinsic fluorescence emission of intact oxy hemoglobins. Biochem Biophys Res Commun 1980, 93:432-439.
68. Hirsch R.E., Nagel R.L. Conformational studies of hemoglobins using intrinsic fluorescence measurements. J Biol Chem 1981, 256:1080-1083.
69. Tan S., Liang C.R., Yeoh K.G., So J., Hew C.L., Chung M.C. Gastrointestinal fluids proteomics. Proteomics Clin Appl 2007, 1:820-833.
70. Muretto P., Graziano F., Staccioli M.P., Barbanti I., Bartolucci A., Paolini G., et al. An endogastric capsule for measuring tumor markers in gastric juice: an evaluation of the safety and efficacy of a new diagnostic tool. Ann Oncol 2003, 14:105-109.
71. Ryu J.W., Kim H.J., Lee Y.S., Myong N.H., Hwang C.H., Lee G.S., et al. The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 2003, 18:505-509.
72. Jang J.S., Cho H.Y., Lee Y.J., Ha W.S., Kim H.W. The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 2004, 14:491-499.
73. Ebert M.P., Kruger S., Fogeron M.L., Lamer S., Chen J., Pross M., et al. Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics 2005, 5:1693-1704.
74. Melle C., Ernst G., Schimmel B., Bleul A., Kaufmann R., Hommann M., et al. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach. J Proteome Res 2005, 4:1799-1804.
75. Lim B.H., Cho B.I., Kim Y.N., Kim J.W., Park S.T., Lee C.W. Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med 2006, 38:455-465.
76. Yoshihara T., Kadota Y., Yoshimura Y., Tatano Y., Takeuchi N., Okitsu H., et al. Proteomic alteration in gastric adenocarcinomas from Japanese patients. Mol Cancer 2006, 5:75.